Lymphoma Flashcards

1
Q

What are lymphomas?

A

malignancies that develop from lymphocytes. The site of the maturation defines the type of lymphoma present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinically, what can lymphomas do to people?

A
  • mass presence (LAD, ureteral obstruction, cord compression)
  • replacement (pancytopenia)
  • reduction (hypogammaglobinemia)
  • tumor products (uric acid, calcium lysis)
  • paraneoplastic (AHA, ITP, neuropathy)
  • toxicity of therapy (infected, numb and short of breath)

-psychosocial/economic: broke and alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What things does a physician need to know if order to treat a lymphoma patient?

A
  • tumor histology
  • tumor stage
  • condition of patent
  • available therapies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is lymphoma histology divided clinically?

A

indolent
aggressive
highly aggressive
B or T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are indolent (low grade) lymphomas?

A

slowly progressive, tend to be higher stage (more widespread), and tend to respond to simple therapies

tend to be incurable (except stage I-II)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T or F. Survival of indolent lymphoma is independent of early treatment

A

T. Treatment is more based on symptomatic presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some examples of indolent lymphomas?

A
  • follicular (most common indolent)
  • small lymphocytic/CLL
  • MALT lymphomas
  • Mycosis fungoides

not curable mostly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do aggressive lymphomas look like?

A

often lower stage, rapidly progressive, requires complex therapies

tend to be curable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T or F. Survival of aggressive lymphoma is independent of early treatment

A

F. Early therapy required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some examples of aggressive lymphomas?

A
  • diffuse large B cell
  • mantle cell
  • peripheral T cell lymphoma (NOS, anaplastic, angioimmunoblastic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some examples of highly aggressive lymphomas?

A
  • Burkitt/ Burkitt like

- T cell lymphoblastic lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a “stage 1” lymphoma?

A

single node or lymphoid structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a “stage 2” lymphoma?

A

two+ lymph regions on one side of the diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a “stage 3” lymphoma?

A

lymph nodes on both sides of diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a “stage 4” lymphoma?

A

disease is extranodal beyond E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is stage I/II E?

A

lymphoma originated in an extra nodal area and spread to adjacent lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some tests used in staging lymphoma patients?

A
  • H&P
  • chest, abdomen, and pelvis CAT
  • PET scan
  • bone marrow aspirate and biopsy (CD20)
  • CBC, LDH, check CSF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does a PET scan allow?

A

irradiates nuclei so that you can see functional changes in lymph nodes in lymphoma whereas normal lymph nodes would not show up on the PET scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the most common lymphoma?

A

diffuse large B cell (then follicular)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the International Prognosis Index?

A
Age>60                         1
Stage  III-IV                   1
LDH elevated               1
P status >1                     1                       
Extranodal sites > 1      1

APLES

Low risk: 0-1
Low intermediate risk: 2
High intermediate risk: 3
High risk: 4

5 yr. Survival
0-1    73%
2       51%
3       43%
4-5    26%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the Follicular lymphoma IPI?

A
Age > 60
Nodal sites > 4 
LDH increased
Stage III-IV
Hemoglobin 
0-1 = 90% 5 yr sv
2 = 77% 5 yr sv
3-5 = 52% 5 yr sv
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are some therapy options for indolent lymphomas?

A

remember, don’t treat unless symptomatic

  • local irradiation
  • Alkylators and prednison
  • Anthracyclines
  • Fludarabine
  • CD20 antibodies
  • Combo chemo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are some therapy options for aggressive lymphomas?

A
  • combo chemo-CHOP; HyperCVAD
  • antibody therapy plus CHOP (rituximab)
  • radio-immunotherapy
  • autologous BM transplant for relapse (survival advantage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is CHOP?

A

cyclophosphamide, hydroxydaunorubicin,
oncovin (vincristine),
prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the antibody drug against CD20?

A

Rituximab- activates complement or phagocytosis

26
Q

T or F. Adding rituximab to CHOp therapy for diffuse B cell lymphoma helps a lot

A

T. Almost always use R-CHOP therapy

27
Q

What is the current therapy for stage I/II (IE/IIE) intermediate grade NHL?

A

CHOP-3 plus RT (stage 1-83% 5 yr survival; stage II-74%)

28
Q

What is the current therapy for stage bulky II/IIE, III, and IV intermediate grade NHL?

A

CHOP-8

stage II bulky -49% 5 yr survival; stage III/IV-46%

29
Q

What is the current therapy for first relapse for all stages of intermediate grade NHL?

A

autotransplant (53% 5 yr survival)

DHAP (32% 5 yr survival)

30
Q

What drug targets CD52 (B and T cells)?

A

alemtuzumab

31
Q

What drug targets CD30 (common on Hodgkin lymphoma)?

A

brentuximab vedotin

32
Q

What drug targets BTK?

A

ibrutinib

33
Q

What drug targets CD22?

A

inotuzumab ozogamicin

34
Q

Describe the B cell receptor pathway

A

Antigen binding induces the aggregation of the BCR with its coreceptors CD79A and B, which become phosphorylated by the tyrosine kinases LYN and SYK. SYK activates phosphoinositide 3–kinase (PI3Kδ), which in turn converts phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate PIP3. PIP3 serves as a docking site for the cytoplasmic kinases Bruton’s tyrosine kinase (BTK) and AKT. BTK phosphorylates and thereby activates phospholipase C gamma 2 (PLCγ2), which in turn generates a set of second messengers to activate protein kinase C beta (PKCβ). PKCβ phosphorylates IκB kinase (IKK) to activate nuclear factor κB (NF-κB) transcription factors that regulate gene expression of several survival factors. The kinases inhibited by small molecules with promising clinical activity are indicated.

35
Q

What drug inhibits SYK?

A

Fostamatinib

36
Q

What drug blocks PI3Kδ?

A

Idelalazib (GS-1101)

37
Q

What infections are associated with lymphoma?

A

HIV (primary CNS lymhpoma)
HHV8, (primary plueral effusion lymphoma)
HTLV-1, (T cell lymphomas-ATLL)
EBV, (Burkitt)
H. pylori (MALT type lymphomas of GI tract)

38
Q

What organ does mycosis fungicides (MF) target primarily?

A

skin (when blood is involved- Sezary)

39
Q

How is early stage MF treated?

A

Soralin (sp?) and UV light only

when disease becomes systemic, need radiation

40
Q

What are some T cell lymphomas?

A
  • Angioimmunoblastic T cell (AITL)
  • Anaplastic large cell
  • Adult T-cell leukemia/lymphoma (ATLL)
41
Q

T or F. ALK+ is favorable in anaplastic large cell lymphoma patients

A

T. Mediastinal presentation in young adults

42
Q

What is AITL associated with?

A
  • hypergammaglobinemia

- AHA

43
Q

What are the types of Hodgkin’s disease?

A

1) lymphocyte predominant (in between indolent and aggressive B cell lymphoma)

2) Classical Hodgkin’s
- lymphocyte rich
- nodular sclerosis
- mixed cellularity
- lymphocyte depleted (more aggressive)

44
Q

What is the most common type of classical hodgkin’s in children?

A

nodular sclerosis. As you get older, mixed cellularity and lymphocyte depleted become more common

45
Q

How is Hodgkin’s Disease different than NHL?

A

-Hodgkin is CD30+

progress differently (goes from one lymph node to the next)

same staging and tests

46
Q

How is early stage Hodgkin treated?

A

Treat with short course chemotherapy and focal radiation to area of disease or radiation alone or chemo alone

47
Q

How is late stage Hodgkin treated?

A

chemotherapy
-ABVD: adriomycin, bleomycin vinblastine, DTIC

-good prognosis

48
Q

The problem with Hodgkin disease is that they live a long time and may develop complications (via chemo) like:

A
  • Acute leukemia and myelodysplasia
  • Solid tumors-breast, lung, stomach, bone, soft tissues
  • Coronary artery disease
  • Radiation and chemotherapy pneumonitis
  • Infertility
  • Hypothyroidism
49
Q

What is chronic lymphocytic leukemia (CLL)?

A

-indolent B cell malignancy

50
Q

patient population for CLL?

A

50+ y/o

51
Q

Symptoms of CLL?

A

Often asymptomatic (may never need treatment)

Lymphocytosis
Lymphadenopathy
Splenomegaly
Anemia (from AHA)
Autoimmune cytopenias
Hypogammaglobulinemia
52
Q

What is RAI staging for CLL?

A
0 = lymphocytosis
1 = enlarged lymph nodes
2= hepatosplenomegaly
3 = Hgb less than 10 (non-immune)
4 = Platelets less than 100,000 (non-immune)
53
Q

What is Binet staging for CLL?

A

based on lymph node involvement:

A=0-2 areas
B=> 2 areas
C= Hgb less than 10 or platelets less than 100K

54
Q

What are some negative prognostic indicators for CLL?

A

High Stage

Increased rate of lymphocyte doubling time (double in less than 6 months is bad)

Beta 2 microglobulin elevated (poor)

Deletion 17p, TP53 mutations, 11q deletion (very bad)

Unmutated VH genes, ZAP-70, CD 38

55
Q

How is CLL treated?

A

Alkylator: Chlorambucil, cyclophosphamide, bendamustine

Purine analogues: Fludarabine

Chemotherapy combinations: FCR

Immunotherapy: rituximab (CD 20), alemtuzumab (CD 52), ibrutinib (if p53 mutation is present)

Radiation

Corticosteroids

56
Q

What is Hairy cell lymphoma (HCL)?

A

indolent B cell lymph proliferative disorder

57
Q

Are men or women more likely to be affected by HCL?

A

male (4:1)

58
Q

Symptoms of HCL?

A
  • splenomegaly
  • pancytopenia
  • decreased cell mediated immunity
59
Q

Immunophenotype of HCL?

A

11c,19,20,22,25,103

60
Q

What are the treatment indications for HCL?

A

Treatment Indications:
Cytopenias
ANC

61
Q

Treatment for HCL?

A

Very high and enduring response rates to 2- chlorodeoxyadenosine and deoxycoformycin